1. Market Research
  2. > Oragenics, Inc. - Product Pipeline Review - 2013

Oragenics, Inc. - Product Pipeline Review - 2013

  • October 2013
  • -
  • Global Markets Direct
  • -
  • 26 pages

Oragenics, Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Oragenics, Inc. - Product Pipeline Review - 2013” provides data on the Oragenics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Oragenics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Oragenics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Oragenics, Inc. - Brief Oragenics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Oragenics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Oragenics, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Oragenics, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Oragenics, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Oragenics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Oragenics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Oragenics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Oragenics, Inc. and identify potential opportunities in those areas.

Table Of Contents

Oragenics, Inc. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Oragenics, Inc. Snapshot 4
Oragenics, Inc. Overview 4
Key Information 4
Key Facts 4
Oragenics, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Oragenics, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Oragenics, Inc. - Pipeline Products Glance 10
Oragenics, Inc. Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Oragenics, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Oragenics, Inc. - Drug Profiles 12
MU-1140 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
MU-1140-S 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
SMaRT Replacement Therapy 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Oragenics, Inc. - Pipeline Analysis 15
Oragenics, Inc. - Pipeline Products by Therapeutic Class 15
Oragenics, Inc. - Pipeline Products By Target 16
Oragenics, Inc. - Pipeline Products by Route of Administration 17
Oragenics, Inc. - Pipeline Products By Mechanism of Action 18
Oragenics, Inc. - Recent Pipeline Updates 19
Oragenics, Inc. - Company Statement 20
Oragenics, Inc. - Locations And Subsidiaries 24
Head Office 24
Other Locations and Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26



List of Tables

Oragenics, Inc., Key Information 4
Oragenics, Inc., Key Facts 4
Oragenics, Inc. - Pipeline by Indication, 2013 7
Oragenics, Inc. - Pipeline by Stage of Development, 2013 8
Oragenics, Inc. - Monotherapy Products in Pipeline, 2013 9
Oragenics, Inc. - Phase I, 2013 10
Oragenics, Inc. - Preclinical, 2013 11
Oragenics, Inc. - Pipeline By Therapeutic Class, 2013 15
Oragenics, Inc. - Pipeline By Target, 2013 16
Oragenics, Inc. - Pipeline By Route of Administration, 2013 17
Oragenics, Inc. - Pipeline Products By Mechanism of Action, 2013 18
Oragenics, Inc. - Recent Pipeline Updates, 2013 19
Oragenics, Inc., Other Locations 24



List of Figures

Oragenics, Inc. - Pipeline by Indication, 2013 6
Oragenics, Inc. - Pipeline by Stage of Development, 2013 8
Oragenics, Inc. - Monotherapy Products in Pipeline, 2013 9
Oragenics, Inc. - Pipeline By Therapeutic Class, 2013 15
Oragenics, Inc. - Pipeline By Route of Administration, 2013 17

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.